Tumor Marker Test. NGS Genetic Testing for Cancer with PositiveSelect Plus.
560 genes 1000x coverage.
Chemotherapy | Targeted Therapy | Immunotherapy
Advanced Tumor Marker Testing
The test includes Microsatellite Instability (MSI) and Tumor Mutation Burden (TMB) testing on a 560 gene panel which provides accurate indication for immunotherapy options.
For the most accurate TMB calculation at least 300 genes must be tested*
Our brochure explains in detail the benefits of the test as well as what is included.
Detailed and Informative Report
Your report will include:
- Personalised treatment plan
- MSI and TBM
- Clinically actionable mutations
This test is applicable for most cancer types including endometrial cancer, lymph node cancer. The test can be taken with a blood test allowing patients of all ages to use this test. Test results help doctors decide personalised treatment option.
This genetic test for cancer is run with Next Generation Sequencing (NGS testing) technology.
Helped avoid costly option immunotherapy. Took the chemotherapy as treatment for endometrial cancer from the Plus report.
3rd Stage Breast Cancer
It started on lining of the uterus. Plus identified 4 options for further treatment. As a late stage patient I thought there was no further options but now treatment is working. I’ve survived uterine sarcoma.
4th stage lung cancer
Buy PositiveSelect Plus
Comprehensive Testing. Comprehendible Results.
Order Test Now
PositiveSelect Plus, NGS genetic test for cancer, that provides inclusive results by testing 560 genes with industry leading standards. The tumor marker test report will give you treatment options for chemotherapy, targeted therapy and immunotherapy.
Our experts and doctors are happy to guide you.